JPL Wealth Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Other funds holding TRDA
BBA
JPL Wealth Management's TRDA Position: Q3 2026 in Review
JPL Wealth Management opened a new position in Entrada Therapeutics (TRDA) in Q3 2026: 3 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #1597 among its holdings.
132 funds tracked by Wall St. Rank hold TRDA as of Q3 2026.
- JPL Wealth Management held 3 shares of Entrada Therapeutics worth $20 as of Q3 2026.
- Entrada Therapeutics was a new JPL Wealth Management position in Q3 2026.
- Entrada Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q3 2026, its #1597 holding.
- 132 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q3 2026.
Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.